` 603456 (Zhejiang Jiuzhou Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

603456
vs
Shanghai Composite

Over the past 12 months, has underperformed Shanghai Composite, delivering a return of 0% compared to the Shanghai Composite's 9% growth.

Stocks Performance
603456 vs Shanghai Composite

Loading
603456
Shanghai Composite
Add Stock
www.alphaspread.com

Performance Gap
603456 vs Shanghai Composite

Loading
603456
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
603456 vs Shanghai Composite

Loading
603456
Shanghai Composite
Add Stock

Competitors Performance
Zhejiang Jiuzhou Pharmaceutical Co Ltd vs Peers

Shanghai Composite
603456
LLY
JNJ
NOVO B
ROG
Add Stock

Zhejiang Jiuzhou Pharmaceutical Co Ltd
Glance View

Market Cap
13.4B CNY
Industry
Pharmaceuticals

Founded in 1973, Zhejiang Jiuzhou Pharmaceutical Co. Ltd. has steadily navigated the evolving tides of the global pharmaceutical industry with a compelling blend of innovation and traditional business acumen. Rooted in China's dynamic Zhejiang province, the company initially focused on manufacturing basic pharmaceutical intermediates. Over the years, it strategically expanded its operations, becoming a key player in both the Active Pharmaceutical Ingredients (APIs) and Contract Development and Manufacturing Organization (CDMO) sectors. This dual focus has allowed Jiuzhou Pharmaceutical to innovate and offer comprehensive services, ranging from drug development to commercial manufacturing, effectively appealing to a broad range of customers including some of the world's leading pharmaceutical companies. At the heart of Jiuzhou Pharmaceutical's success lies its commitment to research and development, a cornerstone that supports its diversification strategy. The company leverages its extensive expertise and cutting-edge technology to improve existing drugs while also participating in the development of new, patented pharmaceuticals. By fostering strong partnerships with global pharmaceutical giants, Jiuzhou effectively integrates itself into the larger pharmaceutical ecosystem, providing customized solutions that resonate with market demand. This business model not only reinforces its financial growth but also establishes Zhejiang Jiuzhou as an indispensable contributor to advancements in medicine, continually enhancing its reputation on the international stage.

Intrinsic Value
19.4 CNY
Undervaluation 22%
Intrinsic Value
Price
Z
Back to Top